R01 NS070190/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	4
2011	7
2012	5
2013	5
2014	5
2015	6
2016	1
2017	2
2018	1
2020	1
2024	0

1

Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL. Schwab AD, et al. Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21. Neurobiol Dis. 2020. PMID: 31978602 Free PMC article. Review.

2

Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders.

Mosley RL. Mosley RL. J Neuroimmune Pharmacol. 2015 Dec;10(4):522-7. doi: 10.1007/s11481-015-9640-y. Epub 2015 Oct 26. J Neuroimmune Pharmacol. 2015. PMID: 26496777 Review.

3

Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.

Gendelman HE, Anantharam V, Bronich T, Ghaisas S, Jin H, Kanthasamy AG, Liu X, McMillan J, Mosley RL, Narasimhan B, Mallapragada SK. Gendelman HE, et al. Nanomedicine. 2015 Apr;11(3):751-67. doi: 10.1016/j.nano.2014.12.014. Epub 2015 Jan 31. Nanomedicine. 2015. PMID: 25645958 Free PMC article. Review.

4

T cells and Parkinson's disease.

Mosley RL, Gendelman HE. Mosley RL, et al. Lancet Neurol. 2017 Oct;16(10):769-771. doi: 10.1016/S1474-4422(17)30276-4. Epub 2017 Aug 11. Lancet Neurol. 2017. PMID: 28807669 No abstract available.

5

Immunization strategies for Parkinson's disease.

Ha D, Stone DK, Mosley RL, Gendelman HE. Ha D, et al. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S218-21. doi: 10.1016/S1353-8020(11)70067-0. Parkinsonism Relat Disord. 2012. PMID: 22166440 Review.

6

The promise of nanoneuromedicine.

Gendelman HE, Mosley RL, Boska MD, McMillan J. Gendelman HE, et al. Nanomedicine (Lond). 2014 Feb;9(2):171-6. doi: 10.2217/nnm.14.17. Nanomedicine (Lond). 2014. PMID: 24552556 Free article. No abstract available.

7

Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.

Anderson KM, Olson KE, Estes KA, Flanagan K, Gendelman HE, Mosley RL. Anderson KM, et al. Transl Neurodegener. 2014 Nov 13;3(1):25. doi: 10.1186/2047-9158-3-25. eCollection 2014. Transl Neurodegener. 2014. PMID: 25671101 Free PMC article. Review.

8

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.

Gendelman HE, Mosley RL. Gendelman HE, et al. J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50. doi: 10.1007/s11481-015-9639-4. Epub 2015 Oct 31. J Neuroimmune Pharmacol. 2015. PMID: 26520433 Free PMC article. Review.

9

Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.

Gautam N, Roy U, Balkundi S, Puligujja P, Guo D, Smith N, Liu XM, Lamberty B, Morsey B, Fox HS, McMillan J, Gendelman HE, Alnouti Y. Gautam N, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):3110-20. doi: 10.1128/AAC.00267-13. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612193 Free PMC article.

10

Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.

Olson KE, Bade AN, Schutt CR, Dong J, Shandler SJ, Boska MD, Mosley RL, Gendelman HE, Liu Y. Olson KE, et al. Neurotherapeutics. 2016 Jul;13(3):635-46. doi: 10.1007/s13311-016-0449-z. Neurotherapeutics. 2016. PMID: 27329163 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year